Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse

• Published in: PloS one 2015-07, Vol.10 (7), p.e0130564-e0130564
• Main Authors: Mailhiot, Sarah E, Zignego, Donald L, Prigge, Justin R, Wardwell, Ella R, Schmidt, Edward E, June, Ronald K
• Format: Article
• Language: English
• Subjects: Aggrecan; Aggrecans - genetics; Aggrecans - metabolism; Aging; Aging (natural); Alleles; Animal models; Animals; Arthritis; Biocompatibility; Bioluminescence; Biomedical materials; Bone Density Conservation Agents - pharmacology; Cartilage; Cartilage diseases; Cartilage, Articular - drug effects; Cartilage, Articular - metabolism; Cartilage, Articular - pathology; Chondrocytes; Chondrocytes - drug effects; Chondrocytes - metabolism; Collagen; Collagenase; Digestion; Drug delivery; Drug delivery systems; Enzymes; Feasibility Studies; Female; Femur; Gene expression; Gene Expression - drug effects; Genetic engineering; Immunology; Industrial engineering; Journalists; Luciferase; Luciferases - genetics; Luciferases - metabolism; Luminescent Measurements - methods; Male; Matrix protein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Osteoarthritis; Osteoarthritis - genetics; Osteoarthritis - metabolism; Pathogenesis; Pixels; Proteins; Rodents; Studies; Tamoxifen; Tamoxifen - pharmacology; Trachea; Transgenic mice
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0130564

Mouse models are common tools for examining post-traumatic osteoarthritis (OA), which involves cartilage deterioration following injury or stress. One challenge to current mouse models is longitudinal monitoring of the cartilage deterioration in vivo in the same mouse during an experiment. The objective of this study was to assess the feasibility for using a novel transgenic mouse for non-invasive quantification of cartilage. Chondrocytes are defined by expression of the matrix protein aggrecan, and we developed a novel mouse containing a reporter luciferase cassette under the inducible control of the endogenous aggrecan promoter. We generated these mice by crossing a Cre-dependent luciferase reporter allele with an aggrecan creERT2 knockin allele. The advantage of this design is that the targeted knockin retains the intact endogenous aggrecan locus and expresses the tamoxifen-inducible CreERT2 protein from a second IRES-driven open reading frame. These mice display bioluminescence in the joints, tail, and trachea, consistent with patterns of aggrecan expression. To evaluate this mouse as a technology for non-invasive quantification of cartilage loss, we characterized the relationship between loss of bioluminescence and loss of cartilage after induction with (i) ex vivo collagenase digestion, (ii) an in vivo OA model utilizing treadmill running, and (iii) age. Ex vivo experiments revealed that collagenase digestion of the femur reduced both luciferase signal intensity and pixel area, demonstrating a link between cartilage degradation and bioluminescence. In an in vivo model of experimental OA, we found decreased bioluminescent signal and pixel area, which correlated with pathological disease. We detected a decrease in both bioluminescent signal intensity and area with natural aging from 2 to 13 months of age. These results indicate that the bioluminescent signal from this mouse may be used as a non-invasive quantitative measure of cartilage. Future studies may use this reporter mouse to advance basic and preclinical studies of murine experimental OA with applications in synovial joint biology, disease pathogenesis, and drug delivery.